The Cord Blood Registry, in collaboration with the Cord Blood Donor
Foundation, is participating in a Breast Cancer Study at Stanford
University School of Medicine. The study, funded by the Susan G.
Komen Breast Cancer Foundation, will examine the potential links of
the prenatal environment to the risk of breast cancer in women.
Prenatal Cord Blood Registry clients who know they are expecting baby
girls will be offered the opportunity to donate plasma for the study.
The Cord Blood Registry is the nations largest family umbilical
cord blood bank. Umbilical cord blood stem cells can be easily
collected and banked for future use as a type of biological
insurance. Over 12,000 families have chosen to bank stem cells
with the registry.
Seeds of Breast Cancer Planted Very Early?
We are excited about this opportunity of taking advantage of
the unique resources at Cord Blood Registry and Cord Blood Donor
Foundation, said Atsuko Shibata, MD, PhD, assistant professor
of health research and policy at Stanford. The major goal of
this study is to compare estrogen levels in cord blood among female
babies of the four racial/ethnic groups whose breast cancer risk
varies significantly. The study relates to the hypothesis that the
formation of breast cancer could start very early in a womans
life. This is an important research question, and yet difficult to study.
Dr. Shibata, who is the principal investigator, of the study will be
testing samples from baby girls that are of African-American, Asian,
Caucasian, and Hispanic descent.
We look forward to collaborating with the Susan G. Komen Breast
Cancer Foundation, Stanford University School of Medicine, and Cord
Blood Registry on such an important study. Cord blood is not only an
invaluable resource in the treatment of diseases, but equally
important in the area of research, said Gloria J. Ochoa,
president, Cord Blood Donor Foundation.